Trade Summary

5 days ago, RIKER LAUREN, serving as Senior Vice President, Finance at Pacira BioSciences, Inc. (PCRX), sold 6,115 shares at $23.50 per share, for a total transaction value of $143,702.50. Following this transaction, RIKER LAUREN now holds 62,284 shares of PCRX.

This sale represents a 8.94% decrease in RIKER LAUREN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, June 13, 2026 (accepted Jun 12, 9:07 PM ET), 2 days after the trade was made.

Pacira BioSciences, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.